ПЕРВИЧНАЯ НАДПОЧЕЧНИКОВАЯ НЕДОСТАТОЧНОСТЬ

Main Article Content

Аннотация:

Надпочечниковая недостаточность– тяжелое эндокринное заболевание характеризующиеся недостаточной секрецией глюкокортикоидов и/или минералокортикоидов надпочечниками, вследствие нарушения функции надпочечников (первичная надпочечниковая недостаточность) или недостаточной стимуляции надпочечников гипофизарным АКТГ (вторичная надпочечниковая недостаточность) или вследствие гипоталамической дисфункции (третичная надпочечниковая недостаточность, Наиболее частая причина надпочечниковой недостаточности – экзогенное применение стероидных препаратов.

Article Details

Как цитировать:

Халимова , З. ., Алимухамедова , Г. ., Мехманова , С., & Туракулова, Я. (2024). ПЕРВИЧНАЯ НАДПОЧЕЧНИКОВАЯ НЕДОСТАТОЧНОСТЬ. Центральноазиатский журнал образования и инноваций, 3(6), 144–150. извлечено от https://in-academy.uz/index.php/cajei/article/view/33532

Библиографические ссылки:

Husebye ES, Pearce SH, Krone NP, Kampe O. Adrenal insufficiency. Lancet. 2021;397(10274):613–29. https:// doi. Ядь org/ 10. 1016/S0140- 6736(21) 00136xvg b7.вч

vanStaaTP , LeufkensHG , AbenhaimLЧСЯ .СЭ.СюэжюЯetal. Use of oral corticosteroids in the United Kingdom . QJM 2000 ; 93 : 105 – 11 . 2

Tomlinson JW , Holden N , Hills RK et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group . Lancet 2001 ; 357 : 425 – 31.

Arlt W, Allolio B (2003). Adrenal insufficiency. Lancet 361:1881-1893.

Barthel A, Benker G, Berens K, et al.: An update on Addison's disease .ExpClinEndocrinol Diabetes. 2019,127:165-75. 10.1055/a-0804-2715

Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine Society clinical practice guideline. J ClinEndocrinolMetab. 2016;101(2):364-389.

LøvåsK ,Husebye ES . High prevalence and increasing incidence of Addison's disease in western Norway . ClinEndocrinol2002 ; 56 : 787 – 91 .

Claahsen-vanderGrinton HL, Speiser PW, Ahmed SF et al. Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr Rev. 2022;43(1);91-159.

O. Chabre, et al., Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality, Ann. Endocrinol. (Paris) 78 (6) (2017) 490–494.

R.K. Crowley, et al., Central hypoadrenalism, J. Clin. Endocrinol. Metab. 99 (11)(2014) 4027–4036.

MM Erichsen et al., Clinical, Immunological and genetic features of of autoimmune primary adrenal insufficiency: observations from a Norwegian registry, J. Clin. Endocrinol. Metabol. 94(12)(2009)4882-4890.

E Burtman, MO Regelmann, Endocrine Dysfunction in X-linked Adrenoleukodystrophy, Endocrinol. Metab. Clin. North America. 45 (2) (2016) 295-309.

V Chortis et al., Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5alpha-reductase, explaining the need for personalized glucocorticoid and androgen replacement, J Clin. Endocr. Metabol. 98(1)(2013)161-171.

Wolff AB, Breivic L, Hufthammer KO, Grytaas MA, Bratland E, Huseybe ES, et al. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease.

Guran T, Buonocore F, Saka N et al. Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort. J Clin Endocrin Metabol. 2016. 101(1). 284-292.

Saverino S, Falorni A. Autoimmune Addison’s disease. Best Pract Res Clin Endocrinol Metab. 2020. 34(1). 101379.

Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary –adrenal insufficiency. Clin Endocrinol 1987;26:221-6.

Wood JB, Frankland AW, James VH, Landon J. A rapid test of adrenocortical function. Lancet 1965;1:243-5.

Ortiz-Flores AE, Santacruz E et al. Role of sampling times and serum cortisol Cut-off Concentrations on the routine Assessment of adrenal Function Using The Standart Cosyntropin Test in an Academic Hospital from Spain: A Retrospective Chart Review (2018).

Mah P, Jenkins R, Rostami-Hodjegan A et al. Weight-related dosing, timing and monitoring hydrocortisone replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin endocrinol 2006; 64:384-89.

Husebye ES, Pearse SH, Krone NP, Kampe O. Adrenal insufficiency. Lancet (2021) 397;613-29.